Cargando…
Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis
INTRODUCTION: Sepsis is a complex immunological response to infection characterized by early hyper-inflammation followed by severe and protracted immunosuppression, suggesting that a multi-marker approach has the greatest clinical utility for early detection, within a clinical environment focused on...
Autores principales: | Sutherland, Allison, Thomas, Mervyn, Brandon, Roslyn A, Brandon, Richard B, Lipman, Jeffrey, Tang, Benjamin, McLean, Anthony, Pascoe, Ranald, Price, Gareth, Nguyen, Thu, Stone, Glenn, Venter, Deon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219023/ https://www.ncbi.nlm.nih.gov/pubmed/21682927 http://dx.doi.org/10.1186/cc10274 |
Ejemplares similares
-
A novel molecular biomarker diagnostic for the early detection of sepsis
por: Venter, D, et al.
Publicado: (2010) -
A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts
por: McHugh, Leo, et al.
Publicado: (2015) -
A limited set of molecular biomarkers may provide superior diagnostic outcomes to procalcitonin in sepsis
por: Brandon, RB, et al.
Publicado: (2012) -
Down but not out: myocardial depression in sepsis
por: McLean, Anthony S
Publicado: (2012) -
Biomarkers in sepsis
por: Singer, Mervyn
Publicado: (2013)